Is galafold.com Safe? Security Analysis for Amicus Therapeutics, Inc.
https://galafold.comCheck if galafold.com is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for galafold.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Galafold.com is the official patient website for Galafold, an FDA-approved oral therapy for adults with Fabry disease. The site is operated by Amicus Therapeutics, Inc., a medium-sized healthcare company based in the United States. The website provides comprehensive patient education, treatment information, support programs, and resources tailored to patients and healthcare professionals. It maintains a strong market position in the niche pharmaceutical sector focused on rare diseases. Technically, the site employs modern web technologies including Bootstrap, jQuery, and various analytics and marketing tools, ensuring good performance, mobile optimization, and accessibility compliance. Security posture is solid with HTTPS, privacy policies, cookie consent, and data protection officer contact information, though improvements could be made by enabling DNSSEC and security headers. Overall, the website is professional, trustworthy, and compliant with relevant regulations, supporting patient engagement and education effectively.
Detected Technologies
9 urgent findings need attention
9 high
- + 1 more findings in the full report below
Keep galafold.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
OffSeq Observations
No critical findings yet
87/100
DNS Health
3 findings
75/100
Email Security
4 findings
70/100
Network Security
1 finding
100/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Amicus Therapeutics leverages Galafold.com to engage directly with patients affected by Fabry disease, providing educational content, patient stories, and support services including financial assistance. The business model centers on pharmaceutical product promotion and patient support, with a clear segmentation between patients and healthcare professionals via separate domains. The company demonstrates a mature digital presence with integrated marketing and analytics tools, indicating a strategic approach to patient outreach and brand positioning. Partnerships with related domains such as amicusrx.com and galafoldhcp.com reinforce the ecosystem supporting both patients and healthcare providers. The site’s content quality and trust signals such as FDA approval and registered trademarks enhance credibility and market differentiation.
Security Posture Analysis
Comprehensive Security Assessment
The website exhibits a good security posture with enforced HTTPS, use of reCAPTCHA to protect forms, and a cookie consent mechanism aligned with privacy regulations. The presence of a named Data Protection Officer and clear privacy policies indicate compliance with GDPR and US privacy standards. However, the absence of DNSSEC and security headers like Content Security Policy or HSTS suggests room for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The site uses multiple third-party scripts for analytics and marketing, which should be regularly audited to mitigate supply chain risks. Incident response and vulnerability disclosure information are not publicly available, representing a potential compliance gap.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Amicus Therapeutics, Inc.
Official patient site for Galafold, an FDA-approved oral therapy for adults with Fabry disease and an amenable GLA variant. Provides treatment information, patient stories, support programs, and educational resources.
excellent
consistent
Technical Stack
moderate
excellent
excellent
good
Security Assessment
- HTTPS enforced
- Use of reCAPTCHA
- Cookie consent mechanism
- Privacy policy and data protection officer contact
- No exposed sensitive data in HTML
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is professionally designed and well-structured for patient education.
Get this report delivered to your inbox
Receive a summary of the galafold.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Strict-Transport-Security configuration
LOWCurrent value: "max-age= 15768000; includeSubDomains; preload"
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete galafold.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 43 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does galafold.com compare?
See how galafold.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the galafold.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the galafold.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about galafold.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published